Novo Nordisk sues South African drug compounder over copies

The Danish drugmaker is asking the High Court in Pretoria to halt the production and sale of unregistered weight-loss products by local pharmacy iDexis. Novo Nordisk cites safety concerns while authorities report serious quality deficiencies in the compounded medicines.